Location out of bounds
Generic Header Image with Radial Dots

COVID-19 Plasma Donation

Convalescent plasma donations through Versiti Blood Centers to treat COVID-19 patients.

Versiti is collecting plasma from recovered COVID-19 patients to help treat others diagnosed with the virus.

This blood-related treatment – authorized by the FDA as an Emergency Use Authorized (EUA) product – could offer hope to the hundreds of patients who continue to be diagnosed. This treatment would be used by hospitals for the most severely affected patients. Participants must be eligible to donate blood – see eligibility here.

Potential convalescent plasma donors must:

  • Have had a confirmed diagnosis of COVID-19 by physician and laboratory testing
  • Must be symptom free for 14 days before being eligible to donate

Frequently Asked Questions: see FDA.gov Investigational COVID-19 Convalescent Plasma Emergency INDs

If you or your patient qualify as a COVID-19 convalescent plasma donor, please submit the form below with appropriate paperwork if available.  A coordinator in your state will be in contact soon.

CCP Donation Process Graphic

Contact Us About Convalescent Plasma Donation

I am a *:


Hospital (if applicable):

Please do not use returns while completing this field.

State *

ZIP code:

First Name *:

Last Name *:

Contact Number *:

Email *:


Please do not use returns while completing this field.

Please attach required paperwork if applicable.

Upload file:

* Fields are required.

COVID-19 convalescent plasma has not been approved or licensed by FDA; COVID-19 convalescent plasma has been authorized by FDA under an EUA; COVID-19 convalescent plasma is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.


This website uses cookies to ensure you get the best experience on our website. Learn more